Sort
46,585 grants matching “heart failure”
CVD protection mechanisms involving ACE2/Ang-(1-7) axis
$573,986Mohan K. Raizada · University Of Florida · R01 · FY2013 · HL
Cardiac protective mechanisms of melanocortin system activation
$573,891Alexandre Alves Da Silva · University Of Mississippi Med Ctr · R01 · FY2024 · HL
Lipotoxicity and Maintenance of Metabolic Health
$573,863Jean E Schaffer · Joslin Diabetes Center · R01 · FY2024 · DK
CORE--PROTEOMICS
$573,794Jennifer E Van Eyk · Johns Hopkins University · P50 · FY2009 · HL
Blood Pressure and Outcomes in Contemporary Left Ventricular Assist Device Recipients
$573,713Himabindu Vidula · University Of Pennsylvania · R01 · FY2024 · HL
IGF-1, Gender, Heart Failure and Longevity: A Paradigm Shift
$573,664Piero Anversa · Brigham And Women'S Hospital · R01 · FY2008 · AG
Mechanistic insights into the deleterious effects of SIRT2 in the heart under stress conditions
$573,568Hossein Ardehali · Northwestern University At Chicago · R01 · FY2021 · HL
Mechanistic insights into the deleterious effects of SIRT2 in the heart under stress conditions
$573,568Hossein Ardehali · Northwestern University At Chicago · R01 · FY2020 · HL
Mechanistic insights into the deleterious effects of SIRT2 in the heart under stress conditions
$573,568Hossein Ardehali · Northwestern University At Chicago · R01 · FY2019 · HL
Mechanistic insights into the deleterious effects of SIRT2 in the heart under stress conditions
$573,568Hossein Ardehali · Northwestern University At Chicago · R01 · FY2018 · HL
Cardiac Lipotoxicity and Ceramide Metabolism in Heart Failure
$573,525P. Christian Schulze · Columbia University Health Sciences · R01 · FY2013 · HL
Glycosphingolipid-Mediated Cardiomyocyte and Immune Cell Dysfunction in Hypoplastic Left Heart Syndrome
$573,504Anastacia M Garcia · University Of Colorado Denver · R01 · FY2024 · HL
The Effects of Interleukin-1 Blockade On Exercise Capacity In Patients With Recently Decompensated Systolic Heart Failure
$573,435Benjamin W Van Tassell · Virginia Commonwealth University · R33 · FY2022 · HL
Molecular regulation of the capillary barrier in acute critical illness
$573,389Richard W Pierce · Yale University · R01 · FY2024 · HL
LIPID BIOMARKERS FOR DIABETIC COMPLICATIONS
$573,276Daniel S Ory · Washington University · R01 · FY2009 · HL
Longitudinal Cardiotoxicity in Adult Survivors Childhood Cancer
$573,170Gregory Armstrong · St. Jude Children'S Research Hospital · R01 · FY2014 · CA
Druggable Mitochondrial Targets for Treatment of Cerebral Ischemia
$573,142Robert S. Clark · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · NS
Accelerating Delivery of rheumatic heart disease preventive iNterventions in Uganda (ADUNU)
$573,018Andrea Zawacki Beaton · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · HL
Quantitative analysis of left ventriculoplasty: CHF
$572,885Mark B Ratcliffe · Northern California Institute/Res/Edu · R01 · FY2014 · HL
Investigating Cellular Immunometabolic Mechanisms Underlying HIV-Related Cardiovascular Disease Risk
$572,865Michael Jay Corley · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · HL
Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot
$572,851Alexander Egbe · Mayo Clinic Rochester · R01 · FY2022 · HL
Role of mRNA-binding protein tristetraprolin in cardiac mRNA regulation and the development of heart failure
$572,830Hossein Ardehali · Northwestern University At Chicago · R01 · FY2022 · HL
Regulation of FGF23 in Chronic Kidney Disease (CKD) by iron and inflammation
$572,755Nicolae Valentin David · Northwestern University At Chicago · R01 · FY2024 · DK
The Effects of Interleukin-1 Blockade On Exercise Capacity In Patients With Recently Decompensated Systolic Heart Failure
$572,689Benjamin W Van Tassell · Virginia Commonwealth University · R33 · FY2021 · HL
NEXT GENERATION SEQUENCING ADD-ON-PHARMACOGENOMICS RESEARCH NETWROK (PGRN)
$572,671Elaine R Mardis · Washington University · U01 · FY2012 · GM